Blockade of TGF-β in a pancreatic ductal adenocarcinoma model improved the cure rate of mice by decreasing the presence of immune suppressive cells in the TME and enhancing CD8+ T cell infiltration within the tumor (42). This evidence concerns the gene CD8A and pancreatic ductal adenocarcinoma.